CJC-1295 Without DAC

CJC-1295 without Drug Affinity Complex (DAC) is a synthetic peptide analogue of growth hormone-releasing hormone (GHRH), specifically designed to stimulate endogenous growth hormone secretion. Unlike the DAC-conjugated variant, the non-DAC form promotes a pulsatile release pattern that closely mimics physiological secretion, reducing the risk of receptor desensitization. CJC-1295 without DAC is primarily utilized in research studying growth hormone dynamics, tissue repair, and metabolic regulation. Its shorter half-life relative to the DAC-bound form provides enhanced flexibility in experimental protocols requiring more transient stimulation of the growth hormone axis. CJC-1295 without DAC remains a valuable tool for investigators examining endocrine modulation and peptide-based interventions.

This product is intended solely for laboratory research use and is not approved for human or veterinary applications, diagnostic procedures, therapeutic uses, or consumption. All products are sold under the condition that they will be handled exclusively by qualified individuals familiar with their use and potential risks. Any application of this material in humans or animals for therapeutic or diagnostic purposes must comply with the regulations established in 21 CFR 312 and 21 CFR 600.